Enlivex Ltd. (ENLV)
ENLV trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2224
-12.10% on the day
Market cap
$4.4M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ENLV on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Israel |
| IPO year | 2014 |
| SEC CIK | 0001596812 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L3 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-08-17 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-03-25 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-29 |
Source: SEC EDGAR submissions feed, 414 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| JUNS | Jupiter Neurosciences Inc. | $3.36 | +10.53% | $4.4M |
| NCNA | NuCana plc American Depositary Share | $1.05 | -2.78% | $4.4M |
| AZTR | Azitra Inc | $0.0715 | -39.20% | $4.3M |
| PPCB | Propanc Biopharma Inc. | $0.4125 | -6.25% | $4.3M |
| DRMA | Dermata Therapeutics Inc. | $0.8599 | -3.34% | $4.3M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier